Device Surgery

Star Tumor Ablation System

Payments companies reported to CMS as associated with Star Tumor Ablation System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$15Kassociated payments (2023-2025)
98clinicians with associated payments
1company reporting

By year

2023 $1,896
2024 $3,380
2025 $9,918

Payments reported as associated with Star Tumor Ablation System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Diagnostic Radiology $6,075
Vascular & Interventional Radiology $3,872
Interventional Pain Medicine $1,163
Pain Medicine (Anesthesiology) $1,094
Orthopaedic Surgery $466
Anesthesiology $454

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Star Tumor Ablation System

These are the largest totals companies reported as associated with Star Tumor Ablation System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jack Jennings Saint Louis, MO Diagnostic Radiology $2,569.59
Jason Dunleavy Williamsville, NY Diagnostic Radiology $1,822.81
Junjian Huang Birmingham, AL Vascular & Interventional Radiology $1,683.20
Glade Roper Visalia, CA Vascular & Interventional Radiology $942.50
Hemant Kalia Rochester, NY Interventional Pain Medicine $379.90
Roy O'Neil Phoenix, AZ Anesthesiology $361.51
Jayson Brower Spokane, WA Vascular & Interventional Radiology $350.00
Cody Foster Coon Rapids, MN Pain Medicine (Anesthesiology) $350.00
Richard Stayner Edina, MN Pain Medicine (Anesthesiology) $350.00
Tyler Ptacek Rapid City, SD Interventional Pain Medicine $350.00

Prescribed Star Tumor Ablation System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.